Back to
Verition Fund Management LLC
KNSA
6 quarters
Position history for
Verition Fund Management LLC's holdings in Kiniksa Pharmaceuticals International, plc
Yes. Verition holds 7,500 shares of KNSA (Kiniksa Pharmaceuticals International), worth $479,625, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$479,625
Current Shares
7,500
Total Value Change
-$189,707
Total Shares Change
-19,284
Quarter-by-Quarter History
Other major holders of KNSA: FMR LLC, Baker Bros. Advisors LP, BlackRock, Inc.